- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
ABI3 Antibody (N-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP10155a | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP10155a-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
ABI3 Antibody (N-term) - Product info | |
| Application | WB, FC
|
| Primary Accession | Q9P2A4 |
| Other Accession | NP_057512.1, NP_001128658.1 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 39035 Da |
ABI3 Antibody (N-term) - Additional info | |
| Gene ID 51225 | |
| Other Names ABI3; NESH; ABI gene family member 3; New molecule including SH3 | |
| Target/Specificity This ABI3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human ABI3. | |
| Dilution WB~~1:100~500WB~~1:1000 FC~~1:10~50 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions ABI3 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
ABI3 Antibody (N-term) - Protein Information | |
| Name ABI3 | |
| Synonyms NESH | |
| Function May inhibit tumor metastasis (By similarity). In vitro, reduces cell motility | |
| Cellular Location Cytoplasm. Note=Colocalizes with PAK2 at leading edge of cells | |
| Tissue Location Expressed in heart, lung, liver, pancreas, kidney, placenta and at low levels in brain and skeletal muscle | |
ABI3 Antibody (N-term) - Related products
AP10155a: ABI3 Antibody (N-term)
ABI3 Antibody (N-term) - Application data
-
ABI3 Antibody (N-term) (Cat. #AP10155a) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the ABI3 antibody detected the ABI3 protein (arrow).
-
ABI3 Antibody (N-term) (Cat. #AP10155a) flow cytometric analysis of K562 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
ABI3 Antibody (N-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes a member of an adaptor protein family. Members of this family encode proteins containing a homeobox homology domain, proline rich region and Src-homology 3 (SH3) domain, and are components of the Abi/WAVE complex which regulates Rac-dependent actin polymerization. The encoded protein inhibits ectopic metastasis of tumor cells as well as cell migration. This may be accomplished through interaction with p21-activated kinase.
REFERENCES
Venkatesan, K., et al. Nat. Methods 6(1):83-90(2009) Hirao, N., et al. FEBS Lett. 580(27):6464-6470(2006) Ichigotani, Y., et al. Int. J. Mol. Med. 9(6):591-595(2002) Ichigotani, Y., et al. Cancer Res. 62(8):2215-2219(2002) Matsuda, S., et al. J. Hum. Genet. 46(8):483-486(2001)